BeiGene, Ltd. Sponsored ADR is a company in the U.S. stock market and it is a holding in 51 U.S.-traded ETFs. BGNE has around 1.6M shares in the U.S. ETF market. The largest ETF holder of BGNE is the iShares Biotechnology ETF (IBB), with approximately 440.39K shares. Investors may also find of interest that the ETF with the largest allocation to BGNE stock is Global X China Biotech Innovation ETF (CHB), with a portfolio weight of 7.74%. On average, U.S. ETFs allocate 0.97% of BGNE to their portfolios.

Additionally, BGNE is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BGNE as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 45.91%.